Dublin
,
Ireland
3 - 6 February 2026
European Association for Hemophilia and Allied Disorders (EAHAD 2026)
Presentation schedule and materials
Wednesday, 04 February 2026
16:00
- 17:00
ET
Symposium
Refocusing on haemophilia B: Patient-centric approaches to using anti-TFPI
Jerzy Windyga
;
Ana Boban
;
Brian O’Mahony
MATERIALS AVAILABLE
Coming soon
18:30
- 19:30
ET
PO083
POSTER
Concizumab plasma concentration measurements and modelling for personalised dose adjustment in patients with haemophilia A/B with and withoutot inhibitors
Mary Mathias1, Chris Barnes2, Johnny Mahlangu3, Tulika Seth4, Sonata Šaulytė Trakymienė5, Alan Faraj6, Jakob Oemar Gjørret6, Kristoffer Winther Balling6, Thomas Porstmann7, Hermann Eichler8
MATERIALS AVAILABLE
18:30
ET
PO047
POSTER
Non-joint bleeds in patients with haemophilia A or B without inhibitors: Results from the concizumab phase 3 explorer8 study
Víctor Jiménez Yuste1, Ei Kinai2, Renée Brown Frandsen3, Fernanda Martinez Garcia3, Laura Villareal Martinez4, Lynn Malec5, Jerzy Windyga6
MATERIALS AVAILABLE
18:30
- 19:30
ET
PO257
POSTER
Mim8, a novel FVIIIa mimetic bispecific antibody, restores hemostatic thrombin generation ex vivo in patients with acquired hemophilia A
A. Briane1, V. Horvais2, J. Graveleau1, A. Babuty2, N. Drillaud2, C. Ternisien2, M. Trossaert2, M. Fouassier2,*
MATERIALS AVAILABLE
18:30
- 19:30
ET
PO054
POSTER
Patient experience with Mim8 prophylaxis: 52-week patient-reported outcomes in adolescents and adults with haemophilia A (FRONTIER2)
Cédric Hermans¹, Sanjay Ahuja², Hazza Alzahrani³, Cihan Ay⁴, Peter Kampmann⁵, Samya Obaji⁶, Sophie Susen⁷, Ciprian Ionut Tomuleasa⁸, Lize van Vulpen⁹, Amalie Rhode Høgh Nielsen¹⁰, Ilgiz Rakhmatullin¹⁰, Carmen Escuriola-Ettingshausen¹¹
MATERIALS AVAILABLE
18:30
- 19:30
ET
PO055
POSTER
Concizumab efficacy in Haemophilia A/B in an Intra-Patient Comparison vs Previous prophylaxis (Phase 3 Explorer8 study): Post-hoc Sensitivity Analysis
Hermann Eichler1, Anthony KC Chan2, Renée Brown Frandsen3, Fernanda Martinez Garcia3, Allison P Wheeler4, Pratima Chowdary5
MATERIALS AVAILABLE
18:30
- 19:30
ET
PO053
POSTER
Mim8 prophylaxis in children with haemophilia A: 52-week caregiver-reported outcomes from FRONTIER3
Karin Fijnvandraat,1 Rubén Berrueco,2 Matteo Luciani,3 Andrea Paramo Florencio,4 Jay Jay Thaung Zaw,4 Paula Kjöllerström5
MATERIALS AVAILABLE
18:30
- 19:30
ET
PO119
POSTER
Real-world efficacy and safety of concizumab in patients with haemophilia B with inhibitors from the early access program in France
Alexandre Butelet,1 Christine Biron-Andréani,2 Valérie Chamouard,3-4 Catherine Chatelanaz,5 Vincent Cussac,5 Roseline d’Oiron,6-7 Yesim Dargaud,3-4 Stéphanie Desage,4 Hélène Gatti,8 Antoine Rauch,9 Sophie Susen,9 Caroline Galeotti6
MATERIALS AVAILABLE
Friday, 06 February 2026
08:30
- 10:00
ET
OR09
ORAL PRESENTATION
Mim8 prophylaxis in children with haemophilia A: 52-week efficacy and safety outcomes from FRONTIER3
Gili Kenet,1 Manuel Carcao,2 Nita Radhakrishnan,3 Runhui Wu,4 Andrea Paramo Florencio,5 Jay Jay Thaung Zaw,5 Johnny Mahlangu6
MATERIALS AVAILABLE
Keywords